Unspecified GLP-1
Sold by Fitness RX · every unspecified glp-1 record
The register has not established whether this program ships a vial, a pen, or another form. That is a gap in our record, not a statement about the company.
Recorded initial charges
First month
$119
first month, including required fees on record. The published monthly rate excludes one-time and annual fees; introductory and conditional rates may change. Some fee details are unverified or unpublished; this sum does not establish the full amount payable.
| Medication · Starting price, including medication · recorded initial monthly payment | $119 |
|---|
Added from the figures recorded below.
Price
| Term | Per month | Charged today |
|---|---|---|
| Starting price, including medication “As low as $119/mo including medication.” | Per month$119 | Charged today$119 |
Price sources
- Starting price, including medication · fitnessrx.com — read September 2026
We earn nothing from this link. It opens Fitness RX's website without a paid referral.
History
Fewer than two comparable calendar-month readings are available for a price trend. Day- or week-based supplies, introductory offers and unverified payment terms are not connected in this chart.
- September 2026 — Entry added to the register
Sourcing and terms
| Cancellation | b. Cancellation: Subscriptions may be canceled anytime via your account dashboard. Cancelations apply at the end of the current billing cycle. |
|---|
Not yet checked: pharmacy, states, prescriber, membership and consult fee.
Recorded from fitnessrx.com. Unlike the price rows above, these carry a summary rather than a word-for-word quotation, so they are not shown in quotation marks.
Notes
- 1. September 2026 — Fitness RX explicitly says 'As low as $119/mo including medication' — a rare case where the page proactively rules out the exclusion pattern the brief warns about, so this is recorded as a price. However the homepage lists six different product options at that one starting price (Injectable Tirzepatide, Injectable Semaglutide, Sublingual Semaglutide, and brand-name Ozempic®, Wegovy®, Zepbound®) without saying which option the $119 actually applies to, so drug is recorded as unspecified GLP-1 rather than assigned to one specific medication.
Treatment Registry is an independent editorial record. It is not a government registry, a licensing body, or a certification. An entry means we recorded what a company published on a given date. It does not mean we recommend the program, and it does not mean the program is approved by anyone.